Skip to main content
SleepCited

CBD 관련 불면증

A

총 1,152명의 참여자를 대상으로 한 9건의 연구(메타분석 1건, RCT 3건)에 근거합니다. 연구 결과는 혼재되어 있습니다.

<\/script>\n
`; }, get iframeSnippet() { const domain = 'sleepcited.com'; const params = 'ingredient\u003Dcbd\u0026condition\u003Dinsomnia'; return ``; }, get activeSnippet() { return this.method === 'script' ? this.scriptSnippet : this.iframeSnippet; }, copySnippet() { navigator.clipboard.writeText(this.activeSnippet).then(() => { this.copied = true; setTimeout(() => { this.copied = false; }, 2000); }); } }" @keydown.escape.window="open = false" @click.outside="open = false">

Embed This Widget

Style



      
      
    

Widget powered by . Free, no account required.

A

결론

The evidence for CBD as a standalone remedy for insomnia is mixed — some studies show benefits while others do not, so more research is needed before it can be confidently recommended.

  • Results are mixed across 9 studies, even at Grade A evidence level due to study volume
  • A 2025 meta-analysis found inconsistent effects of cannabinoids on sleep quality
  • Some studies used medicinal cannabis blends rather than pure CBD, complicating comparisons
  • Individual responses to CBD for sleep may vary significantly

Key Study Findings

Review
Therapeutic Use of Cannabis and Cannabinoids: A Review.
Dose: None vs: None Outcome: None 효과: SMD=-0.29 (nausea/vomiting); SMD=0.57 (body weight in HIV/AIDS) None

대상 집단: adults using cannabis or cannabinoids for medical purposes

Randomized Controlled Trial n=20 Double-blind
Acute Effects of Oral Cannabinoids on Sleep and High-Density EEG in Insomnia: A Pilot Randomised …
Dose: 10 mg THC and 200 mg CBD vs: Placebo Outcome: Total sleep time and REM sleep parameters 효과: -24.5 min TST; -33.9 min REM sleep p=0.05 (TST); p<0.001 (REM)

대상 집단: Patients with DSM-5 insomnia disorder (16F, mean age 46.1)

Observational Study n=3118
Real-world disproportionality analysis of sleep disturbances associated with antiseizure medications in epilepsy: a pharmacovigilance study.
Dose: None vs: None Outcome: Sleep disturbance signals for ASMs in FAERS 효과: 1570 insomnia reports (most frequent) None

대상 집단: Epilepsy patients on ASMs (FAERS Q1 2004-Q2 2025)

Cohort Study n=155 52 weeks Open-label
Opioid reduction in patients with chronic non-cancer pain undergoing treatment with medicinal cannabis.
Dose: Median 15mg THC + 15mg CBD daily vs: Opioids only (separate cohort) Outcome: Opioid consumption reduction at 12 months 효과: Median 2.7 vs 42.3 mg/day <0.05 (ITT)

대상 집단: Chronic non-cancer pain patients on opioids

Other n=27 56 weeks Open-label
Is highly purified cannabidiol a treatment opportunity for drug-resistant epilepsy in subjects with typical Rett …
Dose: 5-20 mg/kg/day vs: None (single-arm) Outcome: Seizure frequency reduction 효과: 66.6% had seizure reduction, 25.9% >75% None

대상 집단: Rett Syndrome and CDKL5 patients with drug-resistant epilepsy

Randomized Controlled Trial n=30 2 weeks Double-blind
The effect of nightly use of 150 mg cannabidiol on daytime neurocognitive performance in primary …
Dose: 150 mg CBD daily vs: Placebo Outcome: Daytime neurocognitive performance 효과: None >0.05

대상 집단: Adults with primary insomnia

Key Statistics

103

연구

41554

참여자

Mixed

A

등급

Referenced Papers

Clinical psychology review 2025 5 인용
Clinical breast cancer 2025 1 인용
Psychopharmacology bulletin 2025 1 인용
Current psychiatry reports 2024 8 인용
Cannabis and cannabinoid … 2023 28 인용
Journal of primary … 2022 28 인용
Current opinion in … 2021 15 인용
Internal medicine journal 2020 18 인용
Schmerz (Berlin, Germany) 2020 8 인용
Current treatment options … 2019 20 인용
The Medical letter … 2019
Current psychiatry reports 2017 394 인용
Cannabis and cannabinoid … 2016 77 인용
International journal of … 2016 16 인용
Pharmaceuticals (Basel, Switzerland) 2012 194 인용
Occupational medicine (Oxford, … 2012 33 인용
The Urologic clinics … 2002 20 인용

Dosage & Usage

mg = milligrams · mcg = micrograms (1,000× smaller) · IU = International Units

일반적으로 사용되는 용량

sleep:
25-150 mg, 1 hour before bed

상한량: Not established; FDA max studied ~20 mg/kg/day

연구에서 사용된 용량

용량 기간 효과 N
None -- Mixed --
10 mg THC and 200 mg CBD -- Negative 20
None -- Mixed 3118
Median 15mg THC + 15mg CBD daily 52 weeks Positive 155
5-20 mg/kg/day 56 weeks Positive 27
150 mg CBD daily 2 weeks Neutral 30
10 mg/kg/day CBD oral during pregnancy -- Negative --
None -- Positive 141

권장 복용 시간: 1 hour before bed

Safety & Side Effects

보고된 부작용

  • Fatigue
  • Diarrhea
  • Changes in appetite
  • Dry mouth
  • Liver enzyme elevation at high doses

알려진 상호작용

  • CYP3A4/CYP2C19 substrates — CBD inhibits these liver enzymes
  • Blood thinners (warfarin) — CBD may increase warfarin levels
  • Clobazam — CBD significantly increases clobazam levels
  • Sedatives — additive drowsiness

일일 최대 섭취 허용량: Not established; FDA max studied ~20 mg/kg/day

건강기능식품을 복용하기 전에 반드시 의료 전문가와 상담하십시오.

Frequently Asked Questions

Does CBD help with 불면증?
Based on 103 studies with 41,554 participants, there is strong evidence from multiple clinical trials that CBD may support 불면증 management. Our evidence grade is A (Strong Evidence).
How much CBD should I take for 불면증?
Studies have used various dosages. A commonly studied range is 25-150 mg, 1 hour before bed. Always consult your healthcare provider before starting any supplement regimen.
Are there side effects of CBD?
Reported side effects may include Fatigue, Diarrhea, Changes in appetite, Dry mouth. Most side effects are mild and dose-dependent. Consult your doctor if you experience any adverse reactions.
How strong is the evidence for CBD and 불면증?
We rate the evidence as Grade A (Strong Evidence). This rating is based on 103 peer-reviewed studies with 41,554 total participants. The overall direction of effect is mixed.

Related Evidence

FDA 면책 조항: 이 내용은 미국 식품의약국(FDA)의 평가를 받지 않았습니다. 이 웹사이트의 제품 및 정보는 질병의 진단, 치료, 완치 또는 예방을 목적으로 하지 않습니다. 제시된 근거 등급은 발표된 동료 심사 연구에 대한 우리의 분석에 기반하며, 의학적 조언을 구성하지 않습니다. 건강기능식품 복용을 시작하기 전에 반드시 의료 전문가와 상담하십시오.